Structure-Based Optimization of Naphthyridones into Potent ATAD2 Bromodomain Inhibitors

被引：72

作者：

Bamborough, Paul ^{[1
]}

Chung, Chun-wa ^{[1
]}

Furze, Rebecca C. ^{[2
]}

Grandi, Paola ^{[4
]}

Michon, Anne-Marie ^{[4
]}

Sheppard, Robert J. ^{[2
]}

Barnett, Heather ^{[3
]}

Diallo, Hawa ^{[2
]}

Dixon, David P. ^{[1
]}

Douault, Clement ^{[2
]}

Jones, Emma J. ^{[1
]}

Karamshi, Bhumika ^{[1
]}

Mitchell, Darren J. ^{[2
]}

Prinjha, Rab K. ^{[2
]}

Rau, Christina ^{[4
]}

Watson, Robert J. ^{[2
]}

Wemer, Thilo ^{[4
]}

Demont, Emmanuel H. ^{[2
]}

机构：

[1] GlaxoSmithKline Med Res Ctr, Mol Discovery Res, Stevenage SG1 2NY, Herts, England

[2] GlaxoSmithKline Med Res Ctr, Epinova Discovery Performance Unit, Stevenage SG1 2NY, Herts, England

[3] GlaxoSmithKline Med Res Ctr, Flexible Discovery Unit, Stevenage SG1 2NY, Herts, England

[4] GlaxoSmithKline, Mol Discovery Res, Cellzome GmbH, D-69117 Heidelberg, Germany

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2015年 / 58卷 / 15期

关键词：

DISCOVERY;

D O I：

10.1021/acs.jmedchem.5b00773

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

ATAD2 is a bromodomain-containing protein whose overexpression is linked to poor outcomes in a number of different cancer types. To date, no potent and selective inhibitors of the bromodomain have been reported. This article describes the structure-based optimization of a series of naphth-yridones from micromolar leads with no selectivity over the BET bromodomains to inhibitors with sub-100 nM ATAD2 potency and 100-fold BET selectivity.

引用

页码：6151 / 6178

页数：28

共 50 条

[41] Discovery of Benzo[cd]indol-2(1H)-ones as Potent and Specific BET Bromodomain Inhibitors: Structure-Based Virtual Screening, Optimization, and Biological Evaluation
Xue, Xiaoqian
Zhang, Yan
Liu, Zhaoxuan
Song, Ming
Xing, Yanli
Xiang, Qiuping
Wang, Zhen
Tu, Zhengchao
Zhou, Yulai
Ding, Ke
Xu, Yong
JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (04) : 1565 - 1579
[42] Discovery of a potent and selective ATAD2 inhibitor with antiproliferative activity in breast cancer models
Kulkarni, Meghana M.
Winter, Jon
Whalley, David
Dale, Ian
Denz, Christopher
Guan, Nin
Bhavsar, Deepa
Zhang, Andrew
Rasmusson, Timothy
Fretland, Adrian
Guichard, Sylvie M.
MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
[43] Structure-based design:: Potent inhibitors of human brain memapsin 2 (β-secretase)
Ghosh, AK
Bilcer, G
Harwood, C
Kawahama, R
Shin, D
Hussain, KA
Hong, L
Loy, JA
Nguyen, C
Koelsch, G
Ermolieff, J
Tang, J
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (18) : 2865 - 2868
[44] Structure-Based Design of Highly Selective Inhibitors of the CREB Binding Protein Bromodomain
Denny, R. Aldrin
Flick, Andrew C.
Coe, Jotham
Langille, Jonathan
Basak, Arindrajit
Liu, Shenping
Stock, Ingrid
Sahasrabudhe, Parag
Bonin, Paul
Hay, Duncan A.
Brennan, Paul E.
Pletcher, Mathew
Jones, Lyn H.
Chekler, Eugene L. Piatnitski
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (13) : 5349 - 5363
[45] Structure-based optimization of aminopyridines as PKCθ inhibitors
Jimenez, Juan-Miguel
Davis, Christopher
Boyall, Dean
Fraysse, Damien
Knegtel, Ronald
Settimo, Luca
Young, Stephen
Bolton, Claire
Chiu, Peter
Curnock, Adam
Rasmussen, Richele
Tanner, Adam
Ager, Ian
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (14) : 4645 - 4649
[46] Discovery and Structure-Based Optimization of Adenain Inhibitors
Mac Sweeney, Aengus
Grosche, Philipp
Ellis, David
Combrink, Keith
Erbel, Paul
Hughes, Nicola
Sirockin, Finton
Melkko, Samu
Bernardi, Anna
Ramage, Paul
Jarousse, Nadine
Altmann, Eva
ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (08): : 937 - 941
[47] The ATAD2 bromodomain binds different acetylation marks on the histone H4 in similar fuzzy complexes
Langini, Cassiano
Caflisch, Amedeo
Vitalis, Andreas
JOURNAL OF BIOLOGICAL CHEMISTRY, 2017, 292 (40) : 16734 - 16745
[48] Structure-based optimization of aminothiadiazole inhibitors of AKT
Mortensen, Deborah S.
Hegde, Sayee G.
Perrin-Ninkovic, Sophie M.
Bahmanyar, Sogole
McCarrick, Meg
Harris, Roy
Hilgraf, Robert
Lee, Branden G. S.
McKie, Jeff
Nadolny, Lisa
Sapienza, John
Collette, Alice
Cox, Sarah
Gamez, James C.
Hensel, Jennifer L.
Hua, Xuequn Helen
Leisten, Jim
Raymon, Heather K.
Tran, Tam
Narla, Rama Krishna
MEDICINAL CHEMISTRY RESEARCH, 2023, 32 (07) : 1426 - 1435
[49] Structure-based optimization of aminothiadiazole inhibitors of AKT
Deborah S. Mortensen
Sayee G. Hegde
Sophie M. Perrin-Ninkovic
Sogole Bahmanyar
Meg McCarrick
Roy Harris
Robert Hilgraf
Branden G. S. Lee
Jeff McKie
Lisa Nadolny
John Sapienza
Alice Collette
Sarah Cox
James C. Gamez
Jennifer L. Hensel
Xuequn Helen Hua
Jim Leisten
Heather K. Raymon
Tam Tran
Rama Krishna Narla
Medicinal Chemistry Research, 2023, 32 : 1426 - 1435
[50] A Qualified Success: Discovery of a New Series of ATAD2 Bromodomain Inhibitors with a Novel Binding Mode Using High-Throughput Screening and Hit Qualification
Bamborough, Paul
Chung, Chun-wa
Demont, Emmanuel H.
Bridges, Angela M.
Craggs, Peter D.
Dixon, David P.
Francis, Peter
Furze, Rebecca C.
Grandi, Paola
Jones, Emma J.
Karamshi, Bhumika
Locke, Kelly
Lucas, Simon C. C.
Michon, Anne-Marie
Mitchell, Darren J.
Pogany, Peter
Prinjha, Rab K.
Rau, Christina
Maria Roa, Ana
Roberts, Andrew D.
Sheppard, Robert J.
Watson, Robert J.
JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (16) : 7506 - 7525

← 1 2 3 4 5 →